Bepirovirsen leads to functional cure in one fifth of people with long-term hepatitis B
Hepatitis B reactivation is rare after switching from tenofovir, two European studies show
Injectable HIV treatment works for people with poor HIV control in Africa
Hidden hepatitis B infection may compromise dolutegravir / lamivudine treatment
Emergency department opt-out testing is revolutionising HIV and hepatitis diagnosis in England
Hepatitis delta very common in people who inject drugs with HIV and hepatitis B
Re-audit of hepatitis care in European HIV services finds improvement in most areas despite challenges
Biktarvy combination pill may be most effective option for people with HIV and hepatitis B
Metabolic disorders cause liver damage in people with HIV more often than viral hepatitis in lower-income countries
